Phase I study of BNC105P, carboplatin and gemcitabine in partially platinum-sensitive ovarian cancer patients in first or second relapse (ANZGOG-1103)
Lindemann, Kristina, Beale, Philip J., Rossi, Emma, Goh, Jeff C., Vaughan, Michelle M., Tenney, Meaghan E., Martyn, Julie K., Sommeijer, Dirkje, Iglesias, Jose L., Kremmidiotis, Gabriel, Simpson, JereLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-018-3706-5
Date:
October, 2018
File:
PDF, 648 KB
english, 2018